• d mannitol Loss of EZH function as a consequence

  2021-12-02

  

  Loss of EZH2 function as a consequence of nonsense or frameshift mutations has also been detected in a cohort study conducted by Jankowska et al. in chronic myelomonocytic leukemia (CMML) patients, as an early event in cancer development [43]. Although, a recent study in Japan described increased le

• The comparatively low number of H

  2021-12-02

  

  The comparatively low number of H1R agonists is contrasted by the high number of diverse H1R antagonists. Based on pharmacological classification, they are grouped into different generations by considering their target as well as side effects profile. The first generation “antihistamines” consist of

• br Introduction The role of histamine in allergic responses

  2021-12-02

  

  Introduction The role of histamine in allergic responses, anaphylaxis, and gastric MG 149 secretion has been well described in both human and veterinary medicine. New roles for histamine and its receptors, however, have been elucidated over the last two decades (Smuda and Bryce, 2011), and novel

• br Methods br Involvement of HO in rheumatic diseases

  2021-12-02

  

  Methods Involvement of HO-1 in rheumatic diseases Therapeutic strategy targeted HO-1 Based on the researches focusing on the effect of HO-1 in rheumatic diseases, amount of approaches targeting regulation of HO-1 have been arising (See Table 1 for summary). It has been shown that different

• Introduction In the s nitric oxide NO was first

  2021-12-02

  

  Introduction In the 1980s, nitric oxide (NO) was first characterized as critical to both innate immunity and endogenous signaling in animals [[1], [2], [3], [4], [5]]. NO was the first gaseous signaling molecule synthesized by animals to have its biochemical signaling pathway fully described [2]. P

• Sodium Aescinate On the basis of their relative Glu

  2021-12-02

  

  On the basis of their relative Glu transport rates and anion currents, EAATs group into two functionally distinct classes, EAAT1–3 being efficient Glu transporters with small associated macroscopic anion currents and EAAT4–5 low-capacity transporters with predominant anion conductance [18]. The diff

• br Dysregulation of glutamate transporter

  2021-12-01

  

  Dysregulation of glutamate transporter expression and function Aberrant glutamate transporter function and expression are associated with various neurological disorders. Therefore, understanding the underlying mechanisms of EAAT1/2 expression may provide therapeutic targets for treating neurologi

• Glucose uptake a critical metabolic control point in

  2021-12-01

  

  Glucose uptake, a critical metabolic control point in glycolysis, is mediated by the GLUT (SLC2) family of integral membrane transporters (Mueckler and Thorens, 2013). GLUT1 (SLC2A1), one of the most well-studied members of the SLC2 family, exhibits a wide tissue distribution; cell surface expressio

• The expression of GLUT receptors throughout the body could b

  2021-12-01

  

  The expression of GLUT receptors throughout the body could be considered a potential source for off-target effects even for engineered glucose-conjugated nanomedicines, as there are at least 12 types of GLUT transporters in the body, including GLUT1 in erythrocytes and the blood-brain barrier, as we

• Interestingly the subcellular localization of FBPase in

  2021-12-01

  

  Interestingly, the subcellular localization of FBPase in hepatocytes and proximal tubule rgd peptide reveals that FBPase is also able to translocate to the nucleus in these cell types. The nuclear localization of muscle-FBPase was recently reported [35]. This data corroborate our results on the abil

• ADAM has two alternative splicing forms a membrane anchored

  2021-12-01

  

  ADAM12 has two alternative splicing forms, a membrane-anchored long form (ADAM12-L) and a secreted short form (ADAM12-S). Both the long and short forms have metalloproteinase, disintegrin, cysteine-rich, and epidermal growth factor-like domains and can shed pro-heparin binding-epidermal growth facto

• There are limited studies on antibody responses against

  2021-12-01

  

  There are limited studies on antibody responses against HIV-1 integrase antigen. According to previous studies, almost 5 percent of individuals infected with HIV never raise anti-integrase many years (Rikhtegaran Tehrani et al., 2015; Chang et al., 1985). If this rate is identical in individuals in

• Newly identified evidence has put immune checkpoint inhibito

  2021-12-01

  

  Newly identified evidence has put immune checkpoint inhibitors into the spotlight. However, even though they have been reported to achieve optimistic outcomes [67], there is still a provocative question about their limitations [68]. The solid evidence above has provided us with translational values

• The central region of Azalanstat can be substituted with con

  2021-12-01

  

  The central region of Azalanstat can be substituted with connecting alkyl chains of different nature and length. Interesting results were given by compounds with a four or five Dihydrodaidzein synthesis chain, incorporating heteroatoms, such as oxygen (Fig. 2, compound 4) or sulfur, and different f

• Under increased drug pressure more protease

  2021-12-01

  

  Under increased drug pressure, more protease variants with more than one substitution will likely become clinically relevant. The accumulation of additional substitutions can allow RAS variants to emerge that alone are not viable, but in combination can rescue the viral fitness. We previously demons

16055 records 552/1071 page Previous Next First page 上5页 551552553554555 下5页 Last page